Article
Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.
American journal of human genetics - 13 Jul 2012
Tang Weihong, Schwienbacher Christine, Lopez Lorna M, Ben-Shlomo Yoav, Oudot-Mellakh Tiphaine, Johnson Andrew D, Samani Nilesh J, Basu Saonli, Gögele Martin, Davies Gail, Lowe Gordon D O, Tregouet David-Alexandre, Tan Adrian, Pankow James S, Tenesa Albert, Levy Daniel, Volpato Claudia B, Rumley Ann, Gow Alan J, Minelli Cosetta, Yarnell John W G, Porteous David J, Starr John M, Gallacher John, Boerwinkle Eric, Visscher Peter M, Pramstaller Peter P, Cushman Mary, Emilsson Valur, Plump Andrew S, Matijevic Nena, Morange Pierre-Emmanuel, Deary Ian J, Hicks Andrew A, Folsom Aaron R
Abstract excerpt
Activated partial thromboplastin time (aPTT) and prothrombin time (PT) are clinical tests commonly used to screen for coagulation-factor deficiencies. One genome-wide association study (GWAS) has been reported previously for aPTT, but no GWAS has been reported for PT. We conducted a GWAS and meta-analysis to identify genetic loci for aPTT and PT. The GWAS for aPTT was conducted in 9,240 individuals of European...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
